L yme disease is caused by the tick-borne spirochete Borrelia burgdorferi (1) . Patients afflicted with B. burgdorferi can display a wide range of clinical symptoms including erythema migrans, a skin rash at the site of the tick bite, various neurological sequelae, carditis, and arthritis. Although appropriate antibiotic treatment cures Lyme disease, ϳ60% of all individuals who do not receive therapeutic intervention develop arthritis (2) (3) (4) . This subacute arthritis can be effectively modeled using inbred mice, as susceptible strains such as C3H develop severe arthritis in the rear ankle joints by 4 wk after B. burgdorferi infection, whereas other strains such as C57BL/6 develop milder arthritis (5) (6) (7) . Differences in the arthritis severity of these two strains are not due to discrepancies in host defense, as both harbor similar numbers of spirochetes within their ankle joints (7) . Spirochetes are detectable within the arthritic joints of patients, and although components of the adaptive immune response, especially Abs, are important for disease resolution, scid and rag Ϫ/Ϫ mice develop severe arthritis, indicating that B and T cells are dispensable for disease development (8, 9) . Although the TLR2-dependent inflammatory response to the numerous lipoproteins that decorate the outer surface of these bacteria has been implicated in arthritis development (2, 10) , both TLR2
Ϫ/Ϫ and MyD88 Ϫ/Ϫ mice still develop arthritis after B. burgdorferi infection (11) (12) (13) (14) . A clear consensus on the role of NFB-dependent cytokines in arthritis development has not been reached, as numerous studies aimed at addressing this question have yielded conflicting results (10) .
In an attempt to uncover novel pathways regulating arthritis development in C3H, C57BL/6, and C57BL/6 IL-10 Ϫ/Ϫ mice, a previous study conducted in our laboratory using Affymetrix microarray analysis found that the majority of genes induced within the rear ankle joints of C3H mice at 1 wk after B. burgdorferi infection were annotated as IFN responsive. An IFN signature was also observed within the ankle joints of the IL-10 Ϫ/Ϫ mice, albeit with delayed induction kinetics, as this profile was not up-regulated until 2 wk postinfection (15) . Additionally, IFN-responsive genes were also induced within the joints of TLR2 Ϫ/Ϫ mice on both the C3H and C57BL/6 backgrounds by 1 wk following B. burgdorferi infection (16) . Although IFN-␥ has been shown to be dispensable for arthritis development in C3H mice (17) , the role of type I IFN in the generation of Lyme arthritis has not been assessed. There is precedent for consideration of the impact of type I IFN on Lyme arthritis development, as arthritis is a documented side effect of therapeutic administration of type I IFN to hepatitis C and multiple sclerosis patients (18, 19) . Several studies have also established a connection between the production of type I IFN and the development of systemic lupus erythematosus (20 -23) . In addition, Gattorno and colleagues recently described the accumulation of type I IFN-producing cells with a plasmacytoid dendritic cell-like morphology in the synovial fluid and inflamed tissue of juvenile idiopathic arthritis patients (24) . These data suggest that the production of type I IFN may be associated with the development of rheumatoid arthritis in children. Finally, there is evidence that type I IFN can be produced by humans in response to B. burgdorferi infection, as IFN-␣ was detected in peripheral blood and blister fluid obtained from Lyme disease patients with multiple erythema migrans lesions (25) .
This report explores the impact of type I IFN depletion on the development of arthritis in C3H mice as a test of the hypothesis that production of type I IFN by 1 wk postinfection sets the stage for the resultant severe arthritis phenotype exhibited by these mice at later time points.
Materials and Methods

Bacterial culture and mouse infection
C3H/HeN mice were obtained from Charles River Laboratories or the breeding facility of the National Cancer Institute (NCI; Frederick, MD), depending on availability. C57BL/6 mice were purchased from National Cancer Institute, and C3H/HeJ and C3H SCID mice were obtained from The Jackson Laboratory. C3H TLR2 Ϫ/Ϫ mice were originally generated by Deltagen and obtained from Tularik (now Amgen) (26) . C57BL/6 MyD88 Ϫ/Ϫ mice were kindly provided by Dr. S. Akira (Hyogo College of Medicine) (27) , and C57BL/6 TLR9 Ϫ/Ϫ mice were obtained from the Mutant Mouse Resource at the University of California, Davis, CA. C57BL/6 IFN-␣/␤ receptor subunit 1 (IFNAR1) Ϫ/Ϫ mice were a gift from Dr. M.-K. Kaja (University of Washington, Seattle, WA). All mice were housed at the University of Utah Animal Research Center (Salt Lake City, UT) and used with strict adherence to all institutional policies and guidelines established for the care and use of laboratory animals in biomedical research.
A clonal isolate of B. burgdorferi strain N40 (cN40), provided by S. Barthold (University of California, Davis, CA) (6), was propagated in BSKII medium (28) . For infection experiments, 2000 cN40 spirochetes were intradermally injected into the shaved back of 6-wk-old female mice in a volume of 20 l. Uninfected control mice received 20 l of BSKII medium. Mice were sacrificed at 1, 2, or 4 wk postinfection and ankle measurements taken with a metric caliper were compared with preinfection measurements and recorded as the change in ankle measurement (29) . For mock-infected control mice as well as animals euthanized at 1 and 2 wk postinfection, all skin was carefully removed, and both rear ankle joints were excised and separately snap frozen in a dry ice-ethanol bath for subsequent RNA extraction and RT-PCR analysis of IFN-inducible genes.
At 4 wk postinfection, the most swollen ankle joint, as assessed by metric caliper measurement, was excised and placed in 10% neutral-buffered formalin (Sigma-Aldrich). Samples were then decalcified, paraffin embedded, sectioned, and stained with H&E by AML Laboratories. Arthritis severity was assessed in a blinded fashion, and overall scores for joints obtained from both mock-infected and B. burgdorferi-infected mice were assigned based on a scale of 0 (no arthritis) to 5 (most severe arthritis) according to the following parameters: overall lesion appearance, degree of neutrophil infiltration, amount of monocytic infiltration, tendon sheath thickness, and the presence of reactive and reparative responses. The least swollen joint was removed at 4 wk postinfection for quantitative PCR assessment (qPCR) 3 of B. burgdorferi numbers within the joint.
Abs and depletion protocols
The following Abs were purchased from eBioscience and used for flow cytometry analyses: FITC-conjugated anti-DX5 (CD49b) pan-NK cell Ab, PE-conjugated anti-CD3, PE-conjugated anti-Armenian hamster IgG, FITC-conjugated anti-rat IgM, FITC-conjugated anti-CD11c, PE-conjugated anti-B220, and FITC-anti-Hamster IgG. PE-anti-rat IgG2a was purchased from BD Pharmingen. MAR1-5A3, a mouse anti-mouse IgG1 mAb directed against IFNAR1, was used to inhibit type I IFN responses in C3H/HeN mice (30) . The mouse IgG1 mAb MOPC-21 (BioExpress Cell Culture Services) or the mouse anti-human IFNGR1 Ab GIR-208 (31) was used as an isotype control. Groups of five age-matched, female C3H/HeN mice received a i.p. injection of PBS or 2.5 mg of either MAR1-5A3 or an appropriate isotype control 1 day before B. burgdorferi infection. IFN-␥ was neutralized using the hamster H22 mAb (32) . The hamster anti-GST mAb PIP was used as an isotype control. C3H/HeN mice were injected i.p. with 0.5 mg of either H22 or PIP or an equal volume of PBS 2 days before B. burgdorferi infection. H22 (0.25 mg) or PIP (0.25 mg) or PBS was administered on the day of infection (day 0), and booster injections were given every 7 days thereafter for the duration of the study. To block both type I IFN and IFN-␥ responses, an i.p. injection of either 2.5 mg of MAR1-5A3 plus 0.5 mg of H22 or 2.5 mg of MOPC-21 plus 0.5 mg of hamster IgG or an equal volume of PBS was administered 1 day before B. burgdorferi infection. The rabbit polyclonal Ab anti-asialo GM1 (Wako Chemicals) was used to deplete NK cells from C3H mice (33) . Groups of five female, age-matched mice received 50-l (1.8 mg) i.p. injections of ␣-asialo GM1, rabbit IgG (Sigma-Aldrich), or an equal volume of PBS on the day of infection (day 0) and on day 4. Anti-asialo GM1 administration resulted in a 75% depletion of NK and NK T cells from the spleen as assessed by flow cytometry using the FITC-conjugated anti-DX5 (CD49b) pan-NK cell Ab. Plasmacytoid dendritic cells (pDCs) were blocked with the anti-pDC Ag 1 (PDCA-1) mAb (Miltenyi Biotec). Groups of 10 female, age-matched mice were injected i.p. with 500 g of anti-PDCA-1, rat IgG, or an equal volume of PBS 1 day before B. burgdorferi infection. Animals were then boosted with 250 g of anti-PDCA-1 or appropriate controls on the day of infection.
RNA extraction and RT-PCR analysis
Rear ankle joints excised from B. burgdorferi-and 16 mock-infected mice were homogenized in chilled guanidine thiocyanate (Roche) and RNA was extracted via cesium chloride ultracentrifugation (34) . RNA was extracted from cultured cells with TRIzol reagent (Invitrogen) according to the manufacturer's instructions. RNA samples were subsequently reverse transcribed into cDNA as described elsewhere (15) and LightCycler-based PCR amplification was conducted using the LightCycler FastStart DNA Master Plus SYBR Green I kit for the LightCycler 2.0 instrument (Roche), as previously described (35) , or the LightCycler 480 (LC480) SYBR Green I master mix for the LightCycler 480 machine (Roche). The number of transcript copies present in the starting template sample were calculated and normalized to 1000 copies of the mouse ␤-actin gene as mentioned elsewhere (35) . The following primer pairs span introns and were used to amplify cytokines and IFN-responsive transcripts: Oasl2 forward 5Ј-TGG GAAGAAGAAAGGGATGGG-3Ј and Oasl2 reverse 5Ј-GGGTTTGTC CAGAGTGTCCAATC-3Ј; Cxcl9 forward 5Ј-TTGGGCATCATCTTCCT GGAGCAG-3Ј and Cxcl9 reverse 5Ј-GAGGTCTTTGAGGGATTTGT AGTGG-3Ј; Il-6d forward 5Ј-ACAACCACGGCCTTCCCTACTT-3Ј (36) and Il-6b reverse 5Ј-TCTCTGAAGGACTCTGGCTTTGTC-3Ј (LightCycler only); Il-6 forward 5Ј-ACCGCTATGAAGTTCCTCTCTGC-3Ј and Il-6d reverse 5Ј-CCAGAAGACCAGAGGAAATTTTC-3Ј (LightCycler 480 only); Il-12p40 forward 5Ј-AGATGACATCACCTGGACCT-3Ј and Il-12p40 reverse 5ЈGCCATGAGCACGTGAACCGT-3Ј. The primer sequences for ␤-actin gene, Igtp, Iigp1, and 16S rRNA have been reported previously (15, 37) .
DNA extraction and qPCR analysis
DNA was extracted from mouse tissues as described elsewhere (38) using sequential digestions with a 0.1% collagenase A solution and a 0.2 mg/ml proteinase K solution. Following a series of phenol/chloroform extraction and ethanol precipitation steps, the purified DNA was diluted to 5 g/ml for use in qPCR assays. Continuous fluorescence monitoring of PCR with SYBR Green I as the detection dye (Molecular Probes) was conducted with the ntm17 primer pair and normalized to 1000 copies of the mouse nidogen gene as previously described (38) .
Collagenase release of ankle cells
To release cells from the ankle tissue, both rear ankles were excised following skin removal from uninfected or B. burgdorferi-infected C3H or C57BL/6 mice 7 or 14 days postinfection and incubated for 2 h at 37°C in RPMI 1640 (Invitrogen) containing 10% FCS and 1 mg/ml collagenase A (Roche) as described previously (16) . Two-color flow cytometry analysis was conducted to assess whether the numbers of conventional dendritic cells (cDCs) (CD11c ϩ B220 Ϫ ) or pDCs (CD11c ϩ B220 ϩ ) increase in the ankle joints following B. burgdorferi infection. The increase in cDC and pDC cell numbers was calculated relative to values obtained for uninfected mice.
Cell culture
Bone-marrow derived macrophages were isolated from the femurs and tibias of mice as previously described (39) by culture in RPMI 1640 medium (Invitrogen) supplemented with 30% L929 conditioned medium and 20% horse serum (HyClone) demonstrated to be free of Mycoplasma with the MycoProbe Mycoplasma detection kit (R&D Systems). Harvested macrophages were replated in 6-well dishes at a density of 6 ϫ 10 5 /ml in medium lacking serum and containing 1% Nutridoma. After an overnight incubation, the medium was removed and replaced with medium alone or medium containing 7.4 ϫ 10 6 /ml live B. burgdorferi cN40 (washed twice in PBS to remove BSKII components). Macrophages were stimulated at 37°C in 5% CO 2 for 24 h, after which the cells were harvested for RNA extraction.
To select for cDCs using a low-density protocol, bone marrow cells were cultured in RPMI 1640 medium (Invitrogen) containing GM-CSF (provided by R. Daynes, University of Utah), as previously described (40) . Harvested cells were magnetically labeled with anti-CD11c microbeads, applied to MACS columns (Miltenyi Biotec), and the CD11c ϩ cells retained by the column were eluted. The purity of these cells was confirmed via flow cytometry staining using anti-CD11c and anti-B220 Abs. On average, 90% of the cells recovered using this protocol were CD11c ϩ B220 Ϫ . Monocyte-derived dendritic cells (1.5 ml; 1.5 ϫ 10 6 cells) and 1.5 ml of medium only, medium plus 1000 U/ml rIFN␤ (Pestka Biomedical Laboratories InterferonSource), 7.4 ϫ 10 6 /ml live B. burgdorferi, B. burgdorferi plus IFN␤, 10 g/ml anti-OspA (determined to be negative for Mycoplasma) (41), or B. burgdorferi plus anti-OspA were added to 17 ϫ 100-mm snap-cap tubes (Falcon) and incubated for 24 h at 37°C in 5% CO 2 . Cells were then collected by centrifugation and RNA was extracted.
pDCs were isolated from the spleens of mice that had received daily i.p. injections of rFlt3L (BioExpress Cell Culture Services) for 9 days (42). Spleens were removed and dissected into RPMI 1640 medium containing 2 mg/ml collagenase A and 20 g/ml DNase I. pDCs were magnetically labeled with anti-PDCA1 microbeads (Miltenyi Biotec) and recovered via separation over a MACS column, followed by elution of PDCA1ϩ cells. Purity was assessed via flow cytometry analysis using anti-CD11c and anti-B220 Abs. On average, 95% of the cells recovered using this protocol were CD11c ϩ B220 ϩ . pDCs were seeded into 24-well plates at 7 ϫ 10 5 /ml in 1 ml of either complete medium or medium containing the following stimuli: 100 U/ml rIFN-␣ (Pestka Biomedical Laboratories InterferonSource), 7.4 ϫ 10 6 /ml live B. burgdorferi, B. burgdorferi plus IFN-␣, 10 g/ml anti-OspA (41), or B. burgdorferi plus anti-OspA. Following a 24-h incubation at 37°C in 5% CO 2 , cells were harvested for RNA extraction.
Statistics
The nonparametric Mann-Whitney U test was used for data values obtained from PCR, RT-PCR, and histopathological scoring of arthritis lesions. One-way ANOVA with the Bonferroni posttest was used to assess the significance of data obtained from ankle measurements and collagenasedigested ankle joints. All statistical analyses were conducted using GraphPad InStat3 version 3.0b for MacIntosh (GraphPad Software). For all tests, A value of p Ͻ 0.05 was considered significant.
Results
The adaptive immune response is not required for induction of IFN profile genes in C3H mice
Previous studies demonstrated that a large number of IFN-responsive genes were significantly up-regulated by 1 wk after B. burgdorferi infection within the rear ankle joints of arthritis-susceptible C3H mice, but not in mildly arthritic C57BL/6 mice, (15) . Elevated transcription of IFN-responsive genes could be linked to the severe arthritis phenotype manifested by C3H but not C57BL/6 mice at later time points. Alternatively, triggering of these genes might occur as a result of early infiltrating B and T lymphocytes that have been reported to secrete IFN-␥ in response to B. burgdorferi (43) (44) (45) (46) . To distinguish between these two scenarios, C3H scid mice, which develop severe arthritis (9), were infected with B. burgdorferi, sacrificed at 1 wk postinfection, and quantitative RT-PCR of selected IFN-responsive genes was conducted on RNA isolated from both rear ankle joints. Fig. 1 depicts transcript levels obtained for four IFN-inducible genes: the IFN-␥ inducible GTPase gene Igtp (Fig. 1A) ; the IFN-inducible GTPase 1 gene Iigp1 (Fig. 1B) ; the oligoadenylate synthase-like 2 gene, Oasl2 (Fig. 1) , and the T cell recruiting chemokine gene Cxcl9 (Mig) (Fig. 1D ). Although the majority of these genes have been previously annotated as IFN-␥ inducible, increased transcription of these genes can also be triggered by type I IFN (47) (48) (49) . These four genes were selected as representatives of the IFN-responsive profile, as Affymetrix microarray analyses revealed these to be among the most highly up-regulated genes at 1 wk postinfection. For example, both Igtp and Iigp1 expression levels were elevated Ͼ100-fold vs values recorded for uninfected mice (15) . Each of the four examined IFN-responsive gene transcripts were elevated within the ankle joints of C3H scid mice to similar levels, relative to uninfected mice, as those obtained for wild-type C3H mice (Fig. 1 ). These data indicate that early recruitment/stimulation of adaptive lymphocytes is not responsible for the transcription of IFN-responsive genes within the ankle joints of C3H mice at 1 wk postinfection. Instead, induction of these genes is mediated by cells of the innate immune response.
IFNAR1 blockage results in decreased arthritis severity and diminished IFN-responsive gene expression, but does not alter host defense
A previous report by Brown and Reiner demonstrated that C3H IFN-␥ Ϫ/Ϫ mice develop severe arthritis following B. burgdorferi infection, indicating that IFN-␥ is not required for Lyme arthritis development (17) . However, much controversy has remained in the field about the impact of IFN-␥ on arthritis development and resolution (10, 50, 51) . When combined with our observation that IFN-responsive gene induction in C3H scid mice mimics that seen in wild-type mice (Fig. 1) , it is highly probable that transcription of any IFN-inducible gene associated with arthritis development would be triggered by innate immune cells and could be a consequence of type I IFN. In line with this hypothesis, the contribution of type I IFN to Lyme arthritis severity in C3H mice at 4 wk postinfection was assessed using a mouse mAb directed against murine IFNAR1 administered 1 day before infection. Overall, mice injected with the anti-IFNAR1 mAb exhibited reduced ankle swelling compared with values obtained for mice treated with PBS or IgG1. Individually, a broad spectrum of arthritis phenotypes was noted for joints obtained from IFNAR1-blocked mice, ranging from a drastic reduction in ankle swelling for two mice, an intermediate phenotype for two mice, and moderately severe ankle swelling for one mouse ( Fig. 2A) . There was significant concordance between ankle swelling measurements and histopathology, as the two mice exhibiting the least amount of ankle swelling also received greatly reduced lesion scores. A significant reduction in lesion pathology was noted in anti-IFNAR1-treated mice when compared with IgG1-treated mice (Fig. 2B) . Anti-IFNAR1-injected mice displayed decreased edema, fewer neutrophils, and less thickening of the cranial tibial tendon sheath (Fig. 3D ). These observations were in stark contrast to those noted for PBS-or IgG1-treated mice, both of which exhibited extensive edema, neutrophil infiltration, and thickening of the tendon sheath (Fig. 3 , B and C), features that are classic hallmarks of Lyme arthritis (5, 6) . Similar results were also obtained in another experiment. To determine whether blockage of type I IFN impacts immunological clearance of B. burgdorferi, qPCR was conducted on DNA extracted from ankle joints of anti-IFNAR1-injected mice. There was no significant difference in spirochete numbers within the joints of IFNAR1-inhibited mice vs those detected in PBS-or IgG1-treated mice (Fig. 2C) .
To determine whether the decrease in arthritis severity observed as a result of IFNAR1-blockage was linked to a suppression of IFN-inducible genes, the effect of anti-IFNAR1 pretreatment in the triggering of IFN-responsive genes at 1 wk postinfection was also assessed. Transcript levels for all four examined IFN-responsive genes were significantly suppressed within the ankle joints of C3H mice that received the anti-IFNAR1 blocking Ab when compared with message levels obtained for infected mice treated with either PBS or IgG1. The diminished induction of transcription observed for these genes in the presence of anti-IFNAR1 was striking, as message levels were reduced by 68% for Cxcl9, 70% for Iigp1, and 81% for Igtp. Intriguingly, induction of Oasl2 transcription was completely suppressed, as message levels in anti-IFNAR1-treated mice were reduced to the baseline level obtained for uninfected C3H mice (Table I) . Together, these data provide strong evidence that type I IFN is involved in induction of the IFN-responsive profile at 1 wk postinfection. The above results also strongly link type I IFN with arthritis development and indicate that type I IFN may partially exert its proarthritic effects through enhanced transcription of IFN-responsive genes by innate immune cells residing within ankle tissue. The kinetics of B. burgdorferi dissemination within anti-IFNAR1-blocked mice was also monitored at 1 wk postinfection to assess whether the spirochete burden within the rear ankle joints differed between these mice and those receiving IgG1 or PBS before infection. Quantitative RT-PCR using primers specific for 16S rRNA revealed low but overlapping B. burgdorferi numbers within the joints of mice from all treatment groups at 1
IFN␥ blockage has no effect on arthritis development or host defense to B. burgdorferi but does suppress induction of IFN-responsive gene transcripts at 1 and 2 wk postinfection
As an additional test of the selective effect of type I IFN on arthritis development, we decided to inhibit type II IFN. Mice were administered anti-IFN-␥ blocking Ab, PBS, or hamster IgG at various intervals both before and following B. burgdorferi infection. Blockage of IFN-␥ did not impact arthritis development in mice examined at 4 wk postinfection (data not shown), consistent with a previous report that IFN-␥ Ϫ/Ϫ C3H mice develop severe Lyme arthritis similar to that noted in wild-type mice (17) . The effect of IFN-␥ inhibition on B. burgdorferi numbers within ankle tissues at 4 wk postinfection was assessed by qPCR and there were no significant differences in the number of spirochetes detected within the ankle joints of anti-IFN-␥ treated mice, when compared with values obtained for control treatment groups (data not shown). These data support the previous conclusion of Brown and Reiner that the control of spirochete numbers within the ankle joints of infected C3H mice is IFN-␥ independent (17) .
Although arthritis proceeded uninhibited in IFN-␥-blocked mice, anti-IFN-␥-treated mice exhibited a striking 100% reduction in the up-regulated expression of the IFN-responsive genes Igtp and Cxcl9 when compared with mice receiving PBS or hamster IgG at 1 wk postinfection. Iigp1 transcript levels were 97% suppressed in anti-IFN-␥-blocked mice (Table II) . Oasl2 gene induction can be mediated by either type I IFN or IFN-␥ (47, 48). Interestingly, IFN-␥ inhibition caused a 73% suppression of Oasl2 (Table II) . In light of the 100% reduction in Oasl2 message levels obtained with the anti-IFNAR1 blocking Ab (compare Table I and  Table II ), these data suggest that Oasl2-induced expression is more effectively reduced by type I IFN blockage. Our previous microarray study found that although the expression of IFN-responsive genes declined by 2 wk after B. burgdorferi infection, message levels for many transcripts were still severalfold higher than those obtained for uninfected mice (15) . For this reason, the effect of IFN-␥ blockage was also assessed at 2 wk postinfection. Markedly reduced transcript levels (90 -100% suppression) were obtained for Igtp, Iigp1, and Cxcl9, whereas anti-IFN-␥ treatment had little effect on Oasl2, suppressing its expression by only 43% when compared with PBS-and hamster IgG-treated mice (Table II) . Analyses of 16S rRNA transcript levels indicated that similar low levels of B. burgdorferi were present within the joints of mice from all treatment groups at both 1 and 2 wk postinfection (data not shown), indicating that IFN-␥ blockage did not alter the kinetics of bacterial dissemination. Finally, we assessed the effect of simultaneous blockage of both type I IFN and IFN-␥ on the induction of IFN-responsive genes at 1 wk postinfection. Induced expression of all four examined IFN-responsive transcripts was 100% abolished within the joints of C3H mice injected with both anti-IFNAR1 and anti-IFN-␥, as message levels were suppressed below the baseline values obtained for untreated, uninfected mice (Table III) . Together, these results support the unique role of type I IFN in arthritis development but also provide compelling evidence that induction of IFN-responsive genes within the joints of C3H mice at 1 wk postinfection reflects the contribution of both type I and type II IFNs.
pDCs and cDCs traffic to the joints following infection but are not the initial source of B. burgdorferi-induced type I IFN
In an attempt to identify the cell type(s) responding to type I IFN to trigger arthritis development, we next questioned whether dendritic cells, either resident in or trafficking to the joint following infection, are involved in the production of type I IFN and/or in Lyme arthritis development. pDCs have long been recognized as the major producers of and responders to type I IFN, but cDCs also possess the ability to both synthesize and react to type I IFN (52, 53) . To this end, we assessed whether pDCs and/or cDCs traffic to the joint following B. burgdorferi infection. Cells released from collagenase-digested ankle joints excised from C3H mice at 7 and 14 days postinfection were analyzed for CD11c and B220 surface expression and compared with the values obtained from uninfected ankle joints. By 7 days postinfection, an increase in the numbers of both CD11c ϩ B220 Ϫ (myeloid or cDCs) and CD11c ϩ B220 ϩ (pDCs) cells was observed in C3H ankle joints, with even greater numbers observed at 14 days postinfection (Fig. 4) . However, blockage of pDCs in C3H mice using anti-PDCA-1 Ab had no impact on arthritis severity (data not shown). Taken together, these results demonstrate that infiltration of both cDCs and pDCs by 1 wk postinfection may occur as a response to infection and inflammation but that pDCs do not mediate arthritis development in C3H mice. However, because increased numbers of DCs were detected in infected joint tissue as early as 1 wk postinfection, a time frame coincident with that of IFN-responsive gene induction, we also investigated the ability of both splenic pDCs and bone marrowderived cDCs to induce expression of the IFN profile in response to in vitro B. burgdorferi stimulation. Although both cDCs and pDCs exhibited elevated IL-6 and/or IL-12 transcripts and protein (data not shown) in the presence of live B. burgdorferi, IFN-responsive transcripts were not induced in response to bacterial stimulation alone. In addition, pDCs stimulated in the presence of IFN-␣ and B. burgdorferi also failed to up-regulate IFN-inducible genes. However, a synergistic increase in expression was detected in cDCs administered IFN␤ and live spirochetes, suggesting that priming may be required for optimal cDC contribution to the IFN response (Table IV) . It has been reported that pDCs exhibit a diminished capacity for phagocytosis of Ags relative to other APCs, such as cDCs and macrophages (52) . To enhance the ability of pDCs to internalize live bacteria, Ab to the abundantly expressed outer surface protein OspA was added to pDCs or cDCs before the addition of B. burgdorferi. Unexpectedly, incubation of cDCs with an anti-OspA Ab resulted in induction of all four examined IFNresponsive genes, but not in IL-12 or IL-6 transcripts. In the presence of opsonizing Ab, neither Borrelia-stimulated pDCs nor cDCs exhibited further up-regulation of IFN-responsive genes (Table IV). Taken together, the above data strongly imply that whereas DCs may contribute either to the amplification of IFN profile genes or to the resolution of this response in vivo, they are unlikely to be the first cell type driving the transcription of type I IFN-responsive genes in response to B. burgdorferi infection.
Bone marrow-derived macrophage induction of IFN-responsive genes in response to in vitro B. burgdorferi-stimulation is type I IFN-dependent and occurs via a MyD88-independent signaling pathway
Another innate immune candidate cell, the bone marrow-derived macrophage (BMM), was then evaluated for its ability to upregulate IFN-inducible genes in response to B. burgdorferi. Twenty-four hours after the addition of B. burgdorferi, transcripts for Igtp (Fig. 5A) , Iigp1 (Fig. 5B) , Oasl2 (Fig. 5C ), and Cxcl9 (Fig.  5D ) were up-regulated in BMM isolated from both C57BL/6 and C3H/HeN mice. BMM from C3H/HeJ mice, which lack a functional Tlr4 gene (54), also displayed up-regulation of IFN-responsive transcripts, indicating that transcription of these genes was not due to low-level LPS contamination of our B. burgdorferi grown in complex medium ( 
NK cell depletion has no effect on arthritis development or host defense to B. burgdorferi at 4 wk postinfection, but NK cells are major IFN-␥ contributors to induction of the IFN-responsive profile at 1 wk postinfection
Our above results demonstrating that IFN-␥ blockage suppressed IFN-responsive gene transcription without impacting arthritis severity was intriguing (Table I) , especially in light of conflicting data in the field concerning a role for IFN-␥ in Lyme arthritis development (17, 50, 51) . Our finding that IFN-responsive genes are still induced in C3H scid mice (Fig. 1) indicated that cells other than T lymphocytes were responsible for both the type I-and IFN-␥-inducible portions of the profile. NK cells are potent producers of IFN-␥ and have been previously shown to secrete this cytokine in response to B. burgdorferi (55) (56) . NK cells were depleted from C3H mice using anti-asialo GM1 to determine whether these cells impact arthritis development or host defense to B. burgdorferi. Anti-asialo GM1 was used to neutralize NK cells because C3H mice produce the NK1.2 allele, to which there are no commercially available Abs. In agreement with data previously obtained with the footpad-injection model (56) , ankle swelling measurements and histopathological lesion scores obtained for antiasialo GM1-injected mice did not differ significantly from those recorded for PBS-or vehicle-treated animals (data not shown). Similar numbers of spirochetes were present both in the joints of anti-asialo GM1-treated mice and in control mice at 4 wk postinfection ( Table V) , indicating that NK cell depletion does not affect the ability of the host immune system to respond to B. burgdorferi challenge. We also examined whether NK cells are a major source of the IFN-␥ driving the induction of the IFN-profile at 1 wk after B. burgdorferi infection. Strikingly, mice treated with anti-asialo GM1 exhibited a significant reduction (77-98%) in the expression levels of Igtp, Iigp1, and Cxcl9 when compared with message levels obtained for PBS-and rabbit IgG-treated mice. In contrast, Oasl2 message levels were only decreased by 54% within the joints of anti-asialo GM1 treated mice (Table V) , an observation that supports other data presented in this report indicating that the magnitude of Oasl2 expression shows greater dependence on type I IFN. These data clearly demonstrate that NK cells are a major IFN-␥ source contributing to induction of IFN-responsive profile genes at 1 wk postinfection. However, as we have reported here in confirmation of previously published reports (17, 56) , NK cells and IFN-␥ production do not contribute to arthritis development, reinforcing the idea that the entire IFN profile is not required for arthritis development.
Discussion
Distinct severities of Lyme arthritis are found in different strains of inbred mice, providing an opportunity to compare responses to B. burgdorferi infection in joint tissue of mice developing mild vs severe disease. Affymetrix microarray analyses previously conducted in our laboratory demonstrated that a large number of IFNresponsive genes were strongly up-regulated within the joints of C3H mice by 1 wk after B. burgdorferi infection. This gene induction profile was specific to the joints of mice destined to develop severe arthritis and was not found in other tissues of these mice (spleen, ear). Because the genes of this profile are annotated in the literature as being either type I IFN-responsive, IFN-␥-responsive, or both, it was not clear which IFN was governing their induction (15) . Therefore, in this report Abs that block the type I IFN receptor or IFN-␥ were used to determine which of these IFN pathways were responsible for the observed gene expression profile and whether either was involved in arthritis development. Blockage of IFNAR1 before infection with B. burgdorferi was uniquely associated with a reduction in arthritis severity, whereas inhibition of IFN-␥ did not effect arthritis (Figs. 2 and 3 ). Neither signaling pathway was implicated in the control of B. burgdorferi in tissues (Fig. 2 and Table V ). The partial inhibition of arthritis by anti-IFNAR1 is consistent with quantitative trait loci analysis, which has identified at least six quantitative trait loci that are responsible for the greater arthritis severity in C3H mice than in C57BL/6 mice (57, 58) . This clearly supports the concept that additional signaling pathways not influenced by type I IFN continue to contribute to arthritis severity in anti-IFNAR1 Ab-blocked mice. Our data differ from two 1995 reports that found a decrease in arthritis severity and spirochete cultivation following anti-IFN-␥ administration (50, 51) . Although it is difficult to explain this discrepancy, there are significant differences in the infection and arthritis protocols used previously and the more quantitative measures used in the current study. Importantly, our results are in agreement with more recent reports using gene ablations for IFN-␥, which demonstrated that this IFN was not required for arthritis development nor for the control of spirochete numbers within murine joint tissue (17, 59) .
Interestingly, blockage of either type I IFN or type II IFN signaling pathways caused a significant reduction in several of the hallmark transcripts of the C3H IFN profile at 1 wk of infection (Tables I, II , and III). Although type I IFN signaling can result in the phosphorylation and aggregation of different combinations of Stat molecules than those activated by IFN-␥ (60), and although Stat1-independent signaling pathways have been identified for IFN-␥ (61, 62) , overlap between the type I and type II IFN signaling pathways has been well-documented in the literature. Both classes of IFNs trigger the Jak-Stat pathway during their activation and share the ability to activate the transcription factors Stat1 and IFN regulatory factor (IRF) 1 (IRF1) (63) . An additional layer of synergism also exists between type I and type II IFN signaling pathways, as type I IFN induction results in downstream activation of the ISFG3 (Stat1:Stat2:IRF9) complex, and IFN-␥ production increases IRF9 levels (64) . Even so, there was some selectivity, as blocking type I IFN signaling had a greater effect on induction of oasl2 gene transcripts than did blocking of type II IFN. Transcripts for other genes, igtp, iigp, and cxcl9, were more dramatically reduced by IFN-␥ neutralization. These results indicate that the robust up-regulation of all IFN-inducible genes is not required for severe arthritis development, as many were suppressed by anti-IFN-␥ without an effect on arthritis. In support of this idea, a previous study conducted on C3H Stat1 Ϫ/Ϫ mice indicated that Stat1 was dispensable for arthritis development, although exacerbated carditis was observed relative to wild-type mice following B. burgdorferi inoculation into the hind footpad (65) . However, the more complete reduction of oasl2 message by anti-IFNAR1, along with its suppressive effect on arthritis development, suggests a skewed effect toward genes with IFN-stimulated response elements that are classically considered downstream of type I IFN signaling. Thus, these results provide the first evidence linking early induction of type I IFN to the development of severe Lyme arthritis.
Following infection with certain types of viruses, type I IFN produced by fibroblasts and cDCs triggers an IRF7-dependent feedback self-amplification loop, resulting in the synthesis of massive quantities of IFN-␣/␤ by the cell (60) . Blockage of type I IFN in C3H mice with anti-IFNAR1 could choke off this autocrine pathway of IFN-␣/␤ production, resulting in concomitant decreases in inflammation and arthritis severity. Results from infected joint tissue provided a snap shot of the evolution of disease but did not provide insight into the cell types responsible for initiating and amplifying the IFN responses to infection. The observation that C3H scid mice, which develop severe arthritis, also display the IFN-responsive gene profile at 1 wk postinfection indicated that neither T nor B lymphocytes were required for induction of these genes (Fig. 1 ). This finding indicated that the transcription of IFN-responsive profile genes is mediated by cells of the innate immune system. Depletion of NK cells had no effect on arthritis development but did cause reduction in the same transcripts that were suppressed by anti-IFN-␥ (⌻able V). Importantly, oasl2 transcript levels were less dramatically influenced by NK cell depletion than those considered downstream of IFN-␥. This result implicates NK cells in the IFN-␥ response while suggesting that other cell types are the source of the type I IFN linked to arthritis development.
The known involvement of pDCs in the production of type I IFN in viral and pathological responses prompted an assessment of the presence of these cells in the joint tissue of infected C3H mice. Both pDCs and cDCs infiltrate into infected joint tissue by 1 wk postinfection, with greater levels seen at 2 wk following infection (Fig. 4) . However, pDCs cultured in vitro with B. burgdorferi did not generate transcripts of the IFN profile, although induction of IL-12 was demonstrated by both RT-PCR and ELISA analyses (Table IV and data not shown). In contrast, cDCs were able to transcriptionally up-regulate components of the profile in response to B. burgdorferi; however, this required the addition of exogenous type I IFN. Although the above results suggest that dendritic cells may contribute to the amplification of the IFN profile in infected C3H mice, dendritic cells are not likely to be the first responding cell that initiates this unusual response. Although it is possible that primed cDCs may up-regulate IFN-inducible transcripts, it seems likely that another cell type is responsible for the initiation of the type I IFN production following infection.
Type I IFN is readily induced in BMM following infection with a virus or intracellular bacteria (66) . In contrast, little is known about elicitation of type I IFN production in these cells upon extracellular bacterial stimulation. For this reason, we decided to assess whether B. burgdorferi-stimulated macrophages could induce IFN-responsive gene transcripts. BMM incubated with live B. burgdorferi readily induced Igtp, Iigp1, and all other examined IFN-responsive transcripts. Expression of these genes was entirely dependent on type I IFN, as transcripts were completely suppressed in IFNAR1 Ϫ/Ϫ macrophages (Fig. 5) . This observation strongly suggests that type I IFN drives the transcription of IFN-responsive genes in macrophages and emphasizes the usefulness of the macrophage as a model cell to investigate the pathways used by B. burgdorferi to stimulate expression of these genes. Induction of IFN-responsive genes by macrophages and other myeloid cells could heavily contribute to the severely arthritic phenotype exhibited by C3H mice, a scenario that gains credence from the observation that both MyD88 Ϫ/Ϫ and TLR2
Ϫ/Ϫ mice induce IFN-responsive genes and develop severe arthritis following B. burgdorferi infection (11) (12) (13) (14) . Macrophages have also been implicated in the development of rheumatoid arthritis, as has been demonstrated by experiments using the K/B ϫ N serumtransfer model (67) . Experiments conducted with B. burgdorferistimulated BMM derived from TLR2 Ϫ/Ϫ , TLR9 Ϫ/Ϫ , and MyD88 Ϫ/Ϫ mice indicate that a MyD88-independent pathway is being used by the Lyme disease spirochete to induce the IFN profile in these cells.
Results obtained with bone marrow-derived macrophages clearly demonstrate the existence of a new pathway by which B. burgdorferi induces type I IFN, and its absence from IFNAR1 Ϫ/Ϫ macrophages indicates that type I IFN is directly responsible for the downstream induction of IFN-responsive genes. The finding that macrophages from TLR2 Ϫ/Ϫ mice up-regulate IFN-inducible genes when incubated with B. burgdorferi are further illuminating, as there is no recognized signaling pathway emanating from TLR2 to type I IFN. Our results provide compelling evidence for the presence of a sensor for B burgdorferi in macrophages that results in the production of type I IFN. Furthermore, the B. burgdorferi ligand for this receptor appears to be distinct from those previously characterized as activating the TLR2/MyD88 pathway. Others have found that phagocytosis of spirochetes enhances the induction of some proinflammatory cytokines (55, 68) ; therefore, phagocyte-mediated internalization may explain how this extracellular pathogen is able to intersect the upstream components of the type I IFN signaling cascade. However, it has also been reported that MyD88 Ϫ/Ϫ macrophages are defective in the uptake of B. burgdorferi, suggesting that other mechanisms may be involved in induction of the IFN profile (13, 68) . In support of the above-mentioned idea, it has recently been demonstrated that group A Streptococcus, an extracellular bacterium that can survive but not replicate within macrophages, triggers the production of type I IFN via a MyD88-independent pathway (69) . Use of this pathway may be highly relevant for group A Streptococcus pathogenesis, as these streptococci can also cause arthritis. Identification of this MyD88-independent receptor will undoubtedly shed light on the mechanisms used by B. burgdorferi to trigger induction of the IFN profile. In conclusion, we now propose that an intracellular sensor for B. burgdorferi induces type I IFN production and the downstream amplification of type I IFN and type II IFN-inducible genes. Our results are of particular significance, as we have demonstrated that this previously unrecognized signaling pathway is involved in Lyme arthritis development.
